Ryusuke Nambu
15PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jan 03, 2026
Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study.Ryusuke Nambu, Itaru Iwama, Ichiro Takeuchi
|Aug 28, 2025
Growth impairment in Japanese children with inflammatory bowel disease: A multicenter prospective cohort study.Hirotaka Shimizu, Ryusuke Nambu, Nao Tachibana
|Jul 09, 2025
Feasibility and Safety of Small Bowel Capsule Endoscopy in Very Early-Onset Inflammatory Bowel Disease: A Multi-Institutional Study.Shin-Ichiro Hagiwara, Hirotaka Shimizu, Ryusuke Nambu
|Jan 20, 2025
Achievement of duodenal ulcer remission by vedolizumab in children with eosinophilic gastroenteritis.Riki Taniguchi, Ryusuke Nambu, Kayoko Ichimura
|Nov 19, 2024
Long-Term Course and Prognostic Factors in Pediatric Ulcerative Proctitis: A Multicenter Cohort Study.Ayako Miyazawa, Ryusuke Nambu, Hirotaka Shimizu
|Apr 08, 2024
Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.Itaru Iwama, Masashi Yoshida, Ayako Miyazawa
Pageof 3
Frequent Collaborators
7 joint publications
Itaru Iwama
6 joint publications
Takahiro Kudo
6 joint publications
Katsuhiro Arai
4 joint publications
Tatsuki Mizuochi
3 joint publications
Shin-Ichiro Hagiwara
3 joint publications
Hirotaka Shimizu
2 joint publications
Takashi Ishige
2 joint publications
Fumihiko Kakuta
2 joint publications
Mikihiro Inoue
1 joint publications
Toshiaki Shimizu
